跳至主要内容
临床试验/NCT05029843
NCT05029843招募中不适用

Single Large-scale mtDNA Deletion Syndrome Natural History Study

The Champ Foundation2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年3月16日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
2
主要终点
Amylase

研究概览

简要总结

The Single Large-Scale mtDNA Deletion Sydrome: Natural History Study (PS-NHS) aims to collect data on standardized clinical outcomes, store data on the Champ Foundation Registry (CFR) and make this data available to researchers, clinicians, and industry partners who are studying SLSMDS to answer questions regarding the disease, including its causes, potential treatments, and other topics. A secondary aim is to analyze the data to understand research questions relating to the natural history of SLSMDS.

详细描述

This study is a prospective, observational, and longitudinal study intended to track the course of Pearson syndrome and single large scale mitochondrial DNA deletion syndromes (SLSMDS) to identify demographic, genetic, environmental, and other variables that correlate with the diseases development and outcomes. If available, retrospective clinical data may be accessed and used in analyses as well.

The PS-NHS will be conducted at two Center of Excellence sites: the Cleveland Clinic and Children's Hospital of Philadelphia (CHOP).

All PS-NHS data will be entered and stored on the CFR. The CFR exists entirely online.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

性别
All
接受健康志愿者

入选标准

  • Have an active account on the Champ Foundation Registry (CFR) or be willing to create an account on the CFR.
  • Must have a genetic diagnosis of a single large-scale mitochondrial DNA deletion and must upload their genetic report to the CFR.
  • Have a clinical diagnosis or history of Pearson syndrome OR have symptom onset prior to five years of age and a genetic diagnosis of a single large-scale mitochondrial DNA deletion OR in the opinion of the principal investigator the participant is suitable for participating in this study based on clinical presentation.
  • Participants may be of any age or gender, and originate from any country.

排除标准

  • 未提供

结局指标

主要结局

Amylase

时间窗: 2 years

Measured U/L

Phosphate

时间窗: 2 years

Measured mg/dL

Balance test

时间窗: 2 years

Standing balance test. May assessed with an accelerometer. Measured as time in seconds.

EKG PR interval

时间窗: 2 years

Calcium

时间窗: 2 years

Measured as pg/mL

Fructosamine

时间窗: 2 years

Measured mcmol/L

Scale for Assessment and Rating of Ataxia

时间窗: 2 years

the SARA is a physical exam that evaluates symptoms of incoordination. A physician will complete this with exam and it will take approximately 20 minutes to complete.

EKG QRS interval

时间窗: 2 years

Hearing testing

时间窗: 2 years

Assessing hearing frequency in both ears.

EKG rhythm

时间窗: 2 years

Lipid panel

时间窗: 2 years

Total cholesterol, HDL-C, LDL-C, triglycerides. Measured as mg/dL.

TSH

时间窗: 2 years

Measured uIUg/mL

PT/PTT

时间窗: 2 years

Measured in seconds

PEDI-CAT assessment

时间窗: 2 years

The PEDI-CAT is a computerized test that will ask participants about daily life tasks. This assessment will be given to patients 0 to 20 years old and will take approximately 15 minutes to complete.

International Pediatric Mitochondrial Disease Scale

时间窗: 2 years

The International Pediatric Mitochondrial Disease Scale is designed to monitor general disease progression associated with mitochondrial disease in children 0 to 18 years old. It includes a physical examination and evaluation of symptoms and functioning. The International Pediatric Mitochondrial Disease Scale will include a clinician-administered assessment that involves asking participants questions and evaluating participants' movements and responses, as well as a patient survey. The score is expressed as the percentage of items which were feasible to perform. Asterixes (\*) can be scored as well, the total score will change accordingly. E.g. if the parents are not able to indicate the presence of headache, the maximum score of the first domain changes from 103 to 73. If the child is not cooperative during the execution of domain 2 and 3, these items are omitted from the total score.

Coordination test

时间窗: 2 years

9-hold peg test. Measured as time in seconds.

2 or 6 minute walk test

时间窗: 2 years

2-minute walk test (2MWT) ages 3-6 yrs. or 6MWT (ages 6+). Measured as distance in meters.

IGF1

时间窗: 2 years

Measured ng/mL

Columbia Neurological Scale

时间窗: 2 years

The Columbia Neurological Scale is a neurological assessment that includes a general medical exam and a general neurological exam. It will take approximately 30 minutes to complete, and that includes evaluation of nerves, muscles and movement. Columbia Neurological Scale ranges from 0 (abnormal exam) to 76 (normal exam).

Strength test

时间窗: 2 years

Hand grip with Dynamometer. Measured as average value of lbs of grip strength.

Cortisol

时间窗: 2 years

Measured mcg/dL

PTH

时间窗: 2 years

Measured as pg/mL

Vitamin D

时间窗: 2 years

Measured ng/mL

FT4 and T3

时间窗: 2 years

Measured ng/dL

Fasting Plasma Glucose (FPG)

时间窗: 2 years

Measured mg/dL

Height

时间窗: 2 years

Assessed in cm

Orbitofrontal cortex (OFC)

时间窗: 2 years

Assessed in cm

Iron

时间窗: 2 years

Measured ug/dL

Number of transfusions

时间窗: 2 years

Frequency count of number of red blood transfusions and platelet transfusions

Amino acids (plasma and urine)

时间窗: 2 years

Interpretation recorded.

Ptosis/ophthalmoplegia

时间窗: 2 years

Assessed in mm

C-peptide

时间窗: 2 years

Measured ng/mL

Urine protein

时间窗: 2 years

Measured mg/dL

Reticulocytes

时间窗: 2 years

Percentage

Echo

时间窗: 2 years

Assessing valve abnormalities

BNP

时间窗: 2 years

Measured as pg/ml

Growth hormone

时间窗: 2 years

Measured ng/mL

HbA1c

时间窗: 2 years

Measured as a percentage

Lactate

时间窗: 2 years

measured mmol/L

Comprehensive Metabolic Panel

时间窗: 2 years

Electrolytes, transaminases, TP/Albumin, bilirubin, alk phos, creatinine, BUN, GFR. Measured mmol/L.

Lipase

时间窗: 2 years

Measured U/L

Stool elastase

时间窗: 2 years

ug Elastase/g stool

Weight

时间窗: 2 years

Assessed in kg

Complete blood count with differential

时间窗: 2 years

Ferritin

时间窗: 2 years

Measured in ng/mL

Glutathione

时间窗: 2 years

Measured uM

GDF15

时间窗: 2 years

pg/mL

ERG/OCT

时间窗: 2 years

Assessed as normal or abnormal

Magnesium

时间窗: 2 years

Measured mg/dL

Urine amino acids

时间窗: 2 years

Acylcarnitines (plasma)

时间窗: 2 years

Measured as mcmol/L

Organic acids (urine)

时间窗: 2 years

Interpretation recorded.

Visual exam

时间窗: 2 years

Assessing palpebral fissure in mm; distance in mm; eye movement in mm

Cystatin C

时间窗: 2 years

Measured mg/dL

Urine Electrolytes

时间窗: 2 years

Measured mg/dL

Facial dysmorphology assessment

时间窗: 2 years

Assessed with facial photography. Assessing ptosis and/or prominent cheeks/jowls.

次要结局

未报告次要终点

研究者

发起方
The Champ Foundation
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验